REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 100 filers reported holding REPLIMUNE GROUP INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,235,627 | -16.1% | 130,662 | +13.9% | 0.00% | 0.0% |
| Q2 2023 | $2,664,216 | +31.8% | 114,738 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $2,021,840 | -28.4% | 114,487 | +12.3% | 0.00% | -50.0% |
| Q4 2022 | $2,822,855 | +117.2% | 101,977 | +31.2% | 0.00% | +100.0% |
| Q3 2022 | $1,299,760 | -4.5% | 77,725 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $1,360,672 | +1.9% | 77,954 | -0.7% | 0.00% | 0.0% |
| Q1 2022 | $1,334,969 | +200.0% | 78,543 | +387.2% | 0.00% | – |
| Q4 2021 | $445,000 | -5.9% | 16,120 | +1.1% | 0.00% | – |
| Q3 2021 | $473,000 | -20.5% | 15,945 | +3.0% | 0.00% | – |
| Q2 2021 | $595,000 | +38.4% | 15,475 | +9.7% | 0.00% | – |
| Q1 2021 | $430,000 | -21.5% | 14,106 | -1.9% | 0.00% | -100.0% |
| Q4 2020 | $548,000 | +97.8% | 14,374 | +19.5% | 0.00% | – |
| Q3 2020 | $277,000 | +3.0% | 12,033 | +12.1% | 0.00% | – |
| Q2 2020 | $269,000 | – | 10,735 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |